Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03799991 · ClinicalTrials.gov registry record · NA

Vestibular Therapy in Alzheimer's Disease

A NA study of Alzheimer Disease and Vestibular Diseases, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT03799991 is a NA study of Alzheimer Disease and Vestibular Diseases that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 100 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03799991, a NA study of Alzheimer Disease and Vestibular Diseases, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Nearly 2 out of 3 patients with Alzheimer's disease (AD) experience problems with balance and mobility, which places such patients at increased risk of falling. The vestibular (inner ear balance) system plays an important role in balance stability, and vestibular therapy (VT) is well-known to improve balance function in healthy older adults. In this study, the investigators will conduct a first-in-kind randomized clinical trial to evaluate whether vestibular therapy improves reduces falls in patients with AD, in whom this treatment has never been studied.

Interventions

  • BEHAVIORAL Vestibular physical therapy
  • BEHAVIORAL Active control

Study Locations (1)

Maryland

  • Johns Hopkins University School of Medicine - Baltimore

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-08-22
Est. Completion 2027-08-26
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT03799991

The ClinicalTrials.gov registry entry for NCT03799991 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (96% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Vestibular physical therapy is the first listed.

NCT03799991 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03799991 about?

NCT03799991 is a clinical study titled "Vestibular Therapy in Alzheimer's Disease". Nearly 2 out of 3 patients with Alzheimer's disease (AD) experience problems with balance and mobility, which places such patients at increased risk of falling. The vestibular (inner ear balance) system plays an important role in balance stability, and vestibular therapy (VT) is well-known to improv...

What is the current status of trial NCT03799991?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-08-22. Estimated completion is 2027-08-26.

What conditions does trial NCT03799991 study?

This clinical trial studies the following conditions: Alzheimer Disease, Vestibular Diseases, Vestibular Disorder.

What interventions are being tested in trial NCT03799991?

The interventions under investigation include: Vestibular physical therapy (BEHAVIORAL), Active control (BEHAVIORAL).

Who is sponsoring clinical trial NCT03799991?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03799991 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.